Table of Contents Table of Contents
Previous Page  1164-1165 / 2063 Next Page
Information
Show Menu
Previous Page 1164-1165 / 2063 Next Page
Page Background

Time (months)

Local control (%)

44 patients

79 patients

21 patients

12 patients

larynx

oropharynx

hypopharynx

oral cavity

ARCON phase II trial